MEI Pharma (MEIP) just threw Wall Street a curveball by swapping part of its cash pile for Litecoin (LTC) and inviting ...

MEI Pharma, Inc. (NASDAQ:MEIP) saw its stock more than double following the announcement of a $100 million private placement ...

MEI Pharma raises $100 million to buy Litecoin, boosting stock value and signaling confidence in LTC's future growth.

MEI Pharma has become the first publicly traded company to adopt Litecoin (LTC) as a primary treasury reserve asset.

MEI Pharma, a publicly traded pharmaceutical company, closed a $100 million private placement to turn itself into a litecoin ...

MEI Pharma has taken a major step, becoming the first publicly traded firm on a national exchange to include Litecoin (LTC) as a major treasury reserve asset. Starting with a $100 million private ...

MEI Pharma unveils bold $100M Litecoin treasury plan with Titan, GSR, Litecoin Foundation, expanding altcoin adoption beyond ...

MEI Pharma (NASDAQ:MEIP) has launched a $100 million Litecoin (CRYPTO: LTC) treasury program, backed by Titan Partners Group ...

LTC gained more than 12% in the past 24 hours, following two major institutional announcements. First and foremost, Luxxfolio ...

MEI Pharma unveils a $100M Litecoin treasury initiative, gaining Litecoin Foundation support and boosting shares 50% intraday ...

MEI Pharma, Inc. (NASDAQ:MEIP) stock is trading higher on Friday, with a session volume of 35.64 million compared to the ...

One day after MEI Pharma rejected an unsolicited bid from investors Anson Funds Management and Cable Car Capital to take the company private, CEO Daniel P. Gold, PhD left effective immediately. Gold, ...